Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Russmann

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
BMC Gastroenterology|July 6, 2010
Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantationFlorian Bihl, Stefan Russmann, Vanina Gurtner, et al.
Plos One|July 29, 2015
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort StudyHelen Kovari, Stefan Russmann, Bruno Ledergerber, et al.
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Pharmacogenomics|April 4, 2023
The Sixth European Society of Pharmacogenomics and Personalised Therapy CongressRon Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
BMC Gastroenterology|July 6, 2010
Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantationFlorian Bihl, Stefan Russmann, Vanina Gurtner, et al.
Plos One|July 29, 2015
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort StudyHelen Kovari, Stefan Russmann, Bruno Ledergerber, et al.
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Pharmacogenomics|April 4, 2023
The Sixth European Society of Pharmacogenomics and Personalised Therapy CongressRon Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, et al.
Pageof 6